Showing results (1581-1590 of 4,521) with videos related to
Sort By:
Pageof 453
Future Oncology (London, England)|December 6, 2019
A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based studyJin-Song Cai, Hai-Yan Chen, Yuan-Fei Lu, et al.Future Oncology (London, England)|October 31, 2019
LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancerYi Yu, Jia-Tian Dong, Bing He, et al.Future Oncology (London, England)|November 1, 2019
Cigarette smoking promotes cancer-related transformation of oral epithelial cells through activation of Wnt and MAPK pathwayRipon Sarkar, Ankita Das, Ranjan R Paul, et al.Future Oncology (London, England)|December 3, 2019
Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a meta-analysisJunkai Zhang, Weineng Feng, Zhihua Ye, et al.Future Oncology (London, England)|December 4, 2019
Adenoid cystic carcinoma of trachea: long-term disease control after endoscopic surgery and radiotherapyCorrado Spatola, Alessandra Tocco, Dario Marletta, et al.Future Oncology (London, England)|February 13, 2020
The emerging development of tumor mutational burden in patients with NSCLCYu Zhang, Lifeng Wang, Rutian Li, et al.Future Oncology (London, England)|February 12, 2020
Prognostic factors and outcome of HER2+ breast cancer with CNS metastasesGiovanna Masci, Elisa Agostinetto, Laura Giordano, et al.Future Oncology (London, England)|February 5, 2019
The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinomaBeili Wang, Feng Li, Luya Cheng, et al.Future Oncology (London, England)|January 23, 2019
Subgroups of parotid gland infiltrating ductal carcinoma benefit from postoperative radiotherapy: a population-based studyTao Lv, Yujie Wang, Xiaoshen WangFuture Oncology (London, England)|February 8, 2019
Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced agePieternella J Lugtenburg, Alexander R Lyon, Reinhard Marks, et al.Pageof 453